RGT-61159 clinical trials

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

This study is testing a new drug, RGT-61159, for people with advanced adenoid cystic carcinoma (ACC) or colorectal cancer (CRC). It aims to see if the drug is safe and helps shrink tumors. It's for patients whose cancer has come back or spread and who have run out of other treatment options.